• Biotalys announces participation at investor and industry events for the remainder of 2022

    Source: Nasdaq GlobeNewswire / 07 Nov 2022 00:00:00   America/Chicago

    Ghent, Belgium, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Biotalys (Euronext - BTLS), an Agricultural Technology (AgTech) company protecting crops and food with protein-based biocontrol solutions, today announces the upcoming participation of the company in a variety of European investor and business events. Biotalys welcomes the opportunity to engage with institutional and retail investors during these events to share the company’s exciting development since its IPO mid last year.

    North Carolina agriculture investor conference
    November 9, 2022
    Research Triangle Park, NC USA
    Presentation by Patrice Sellès, CEO of Biotalys

    Crop Science Forum & Awards 20222
    November 10, 2022
    Virtual
    Biotalys and its manufacturing partner Olon are finalist in the Award for Best Industry Collaboration

    Kepler Cheuvreux Global AgriFood Forum 2022
    November 14, 2022
    Virtual
    Presentation by Biotalys’ management and 1-2-1 meetings with investors

    German Equity Forum
    November 28-30, 2022
    Frankfurt, Germany
    Presentation by company management and 1-2-1 meetings with investors

    Canaccord Genuity AgriFood Tech Innovations Forum
    December 1, 2022
    Virtual
    Presentation by company management and 1-2-1 meetings with investors

    Biotalys Shareholders Club
    December 8, 2022
    Ghent, Belgium
    Site visit at Biotalys headquarters for retail investors

    Biocontrol & Biomes
    December 13-14, 2022
    Madrid, Spain (hybrid event)
    Presentation by Luc Maertens, COO of Biotalys

    About Biotalys

    Biotalys is an Agricultural Technology (AgTech) company protecting crops and food with proprietary protein-based biocontrol solutions and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply. Based on its novel AGROBODY™ technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and is listed on Euronext Brussels since July 2021. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on www.biotalys.com.

    For further information, please contact

    Toon Musschoot, Head of IR & Communication
    T: +32 (0)9 274 54 00
    E: Toon.Musschoot@biotalys.com

    Important Notice

    This announcement contains statements which are "forward-looking statements" or could be considered as such. These forward-looking statements can be identified by the use of forward-looking terminology, including the words ‘aim’, 'believe', 'estimate', 'anticipate', 'expect', 'intend', 'may', 'will', 'plan', 'continue', 'ongoing', 'possible', 'predict', 'plans', 'target', 'seek', 'would' or 'should', and contain statements made by the company regarding the intended results of its strategy. By their nature, forward-looking statements involve risks and uncertainties and readers are warned that none of these forward-looking statements offers any guarantee of future performance. The Biotalys actual results may differ materially from those predicted by the forward-looking statements. Biotalys makes no undertaking whatsoever to publish updates or adjustments to these forward-looking statements, unless required to do so by law.

    Attachments


Share on,